|
Media Releases |
Financial Reports |
Presen-tations |
|
07/31/2009
|
 |
|
|
| Basel, 31 July 2009 |
Lonza announces a personal change in the Investor Relations Department. Alexandre Pasini, who has been responsible for Investor Relations since April 2007, will become Site Director of the manufacturing and research base of Lonza Bioscience in Verviers (Belgium). Marcel Rosenast, Project Manager in Audit Services since September 2006, will take over the position of Investor Relations Manager, reporting to Michael Frizberg, who will continue to run Corporate Communications & Investor Relations. The changes will become effective September 6, 2009.
For further information and meeting requests, please contact
investor.relations@lonza.com.
About Lonza
Lonza is one of the world's leading suppliers to the pharmaceutical, healthcare and life science industries. Its products and services span its customers’ needs from research to final product manufacture. Lonza is the global leader in the production and support of active pharmaceutical ingredients both chemically as well as biotechnologically. Biopharmaceuticals are one of the key growth drivers of the pharmaceutical and biotechnology industries. Lonza has strong capabilities in large and small molecules, peptides, amino acids and niche bioproducts which play an important role in the development of novel medicines and healthcare products. Lonza is a leader in cell-based research, endotoxin detection and cell therapy manufacturing. Lonza is also a leading provider of value chemical and biotech ingredients to the nutrition, hygiene, preservation, agro and personal care markets.
Lonza is headquartered in Basel, Switzerland and is listed on the SIX Swiss Exchange. In 2008, Lonza had sales of CHF 2.937 billion. Further information can be found at www.lonza.com.
For further Information
Lonza Group Ltd
Head Corporate Communications
Michael Frizberg
Tel +41 61 316 8624
Fax +41 61 316 9624
michael.frizberg@lonza.com
Lonza Group Ltd
Media Relations
Dominik Werner
Tel +41 61 316 8798
Fax +41 61 316 9798
dominik.werner@lonza.com
Lonza Group Ltd
Investor Relations
Alexandre Pasini
Tel +41 61 316 8835
Fax +41 61 316 9835
alexandre.pasini@lonza.com
|
|
|
